Thyrocare Technologies Limited (THYROCARE) — FY26 Annual Report | 4 June 2026 (3 announcements)

Thyrocare Technologies announced the 26th Annual General Meeting on June 30, 2026, at 11:00 A.M. IST at its Turbhe corporate office, providing web links to the notice and FY2025-26 Annual Report for members who have not registered email addresses, and reminding them to update contact details to continue receiving communications.

Thyrocare Technologies Limited submitted its Business Responsibility and Sustainability Report for FY 2025-26 as part of the Annual Report, disclosing standalone operations, 98.66% revenue from diagnostic services, 1,906 total employees, and 0.05% export contribution. The report outlines material risks including climate exposure, employee health and safety, and governance practices, while highlighting sustainability initiatives like solar adoption and wastewater treatment. Management emphasizes ESG integration through board oversight and stakeholder engagement, with no material changes from prior periods or explicit forward guidance provided.

Thyrocare Technologies Limited announced its 26th AGM on June 30, 2026, in Navi Mumbai, with e-voting available from June 26 to 29. The filing details financial performance, including FY2026 revenue of ₹829.04 Crore, net profit of ₹162.85 Crore, and EBITDA margin of 28%. It highlights strategic expansion in diagnostics, including oncology and genomics, and appoints new directors while reappointing the CEO for a second term. Shareholder resolutions seek approval for related party transactions, auditor appointments, and MOA amendments. Dividend proposals include a final dividend of ₹7.00 per share.